Anita B. Hjelmeland, Ph.D.
Affiliations: | 2003 | Duke University, Durham, NC |
Area:
SomatosensoryGoogle:
"Anita Hjelmeland"Mean distance: 15.4 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hawkins CC, Jones AB, Gordon ER, et al. (2023) Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells. Cell Death Discovery. 9: 451 |
Miller CR, Hjelmeland AB. (2023) Breaking the feed forward inflammatory cytokine loop in the tumor microenvironment of PDGFB-driven glioblastomas. The Journal of Clinical Investigation. 133 |
Jones AB, Schanel TL, Rigsby MR, et al. (2023) Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities. Cells. 12 |
Watson DC, Bayik D, Storevik S, et al. (2023) GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nature Cancer |
Guo Y, Jiang Y, Rose JB, et al. (2022) Protein Kinase D1 Signaling in Cancer Stem Cells with Epithelial-Mesenchymal Plasticity. Cells. 11 |
Marayati R, Julson J, Bownes LV, et al. (2022) PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4. Clinical & Experimental Metastasis. 39: 899-912 |
Hawkins CC, Jones AB, Gordon ER, et al. (2022) Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling. Cells. 11 |
Marayati R, Julson JR, Bownes LV, et al. (2022) Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype. Journal of Pediatric Surgery |
Tuy K, Rickenbacker L, Hjelmeland AB. (2021) Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance. Redox Biology. 44: 101953 |
Williford SE, Libby CJ, Ayokanmbi A, et al. (2021) Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells. Plos One. 16: e0250649 |